APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Medicine for Osteoarthritis Pain

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Medicine for Osteoarthritis Pain Industry Growth and Trends Forecast to 2032

Report ID 174011520120 December 2025113 pages

Choose your research edition.

Industry ResearchMedicine for Osteoarthritis Pain Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Medicine for Osteoarthritis Pain Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Medicine for Osteoarthritis Pain Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Medicine for Osteoarthritis Pain Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Medicine for Osteoarthritis Pain Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

The global Medicine for Osteoarthritis Pain market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Medicine for Osteoarthritis Pain is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Medicine for Osteoarthritis Pain is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Medicine for Osteoarthritis Pain is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Medicine for Osteoarthritis Pain include Abbott, TEVA, Sanofi, Johnson and Johnson, Novartis, Mylan, Eli Lilly, Hengrui Pharmaceutical and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Medicine for Osteoarthritis Pain market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Medicine for Osteoarthritis Pain market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Medicine for Osteoarthritis Pain market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Medicine for Osteoarthritis Pain.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Medicine for Osteoarthritis Pain market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Medicine for Osteoarthritis Pain Market by Company

Abbott

TEVA

Sanofi

Johnson and Johnson

Novartis

Mylan

Eli Lilly

Hengrui Pharmaceutical

Pfizer

GlaxoSmithKline

Daiichi Sankyo

Bayer

Tide Pharmaceutical

Iroko Pharmaceuticals

Horizon Pharma

Astellas Pharma

Almatica Pharma

Abiogen Pharma

Medicine for Osteoarthritis Pain Segment by Type

Injection

External

Oral

Medicine for Osteoarthritis Pain Segment by Application

Medical Care

Personal Care

Medicine for Osteoarthritis Pain Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medicine for Osteoarthritis Pain market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Medicine for Osteoarthritis Pain and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medicine for Osteoarthritis Pain.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Medicine for Osteoarthritis Pain manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Medicine for Osteoarthritis Pain in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Injection Table 2. Major Company of External Table 3. Major Company of Oral Table 4. Global Medicine for Osteoarthritis Pain Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Medicine for Osteoarthritis Pain Sales by Type (2021-2026) & (k units) Table 6. Global Medicine for Osteoarthritis Pain Sales Market Share in Volume by Type (2021-2026) Table 7. Global Medicine for Osteoarthritis Pain Sales by Type (2021-2026) & (US$ Million) Table 8. Global Medicine for Osteoarthritis Pain Sales Market Share in Value by Type (2021-2026) Table 9. Global Medicine for Osteoarthritis Pain Price by Type (2021-2026) & (US$/unit) Table 10. Global Medicine for Osteoarthritis Pain Sales by Type (2027-2032) & (k units) Table 11. Global Medicine for Osteoarthritis Pain Sales Market Share in Volume by Type (2027-2032) Table 12. Global Medicine for Osteoarthritis Pain Sales by Type (2027-2032) & (US$ Million) Table 13. Global Medicine for Osteoarthritis Pain Sales Market Share in Value by Type (2027-2032) Table 14. Global Medicine for Osteoarthritis Pain Price by Type (2027-2032) & (US$/unit) Table 15. North America Medicine for Osteoarthritis Pain Sales by Type (2021-2026) & (k units) Table 16. North America Medicine for Osteoarthritis Pain Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Medicine for Osteoarthritis Pain Sales by Type (2021-2026) & (k units) Table 18. Europe Medicine for Osteoarthritis Pain Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Medicine for Osteoarthritis Pain Sales by Type (2021-2026) & (k units) Table 20. Asia-Pacific Medicine for Osteoarthritis Pain Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Medicine for Osteoarthritis Pain Sales by Type (2021-2026) & (k units) Table 22. Latin America Medicine for Osteoarthritis Pain Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Medicine for Osteoarthritis Pain Sales by Type (2021-2026) & (k units) Table 24. Middle East and Africa Medicine for Osteoarthritis Pain Sales by Type (2021-2026) & (US$ Million) Table 25. Medicine for Osteoarthritis Pain Industry Trends Table 26. Medicine for Osteoarthritis Pain Industry Drivers Table 27. Medicine for Osteoarthritis Pain Industry Opportunities and Challenges Table 28. Medicine for Osteoarthritis Pain Industry Restraints Table 29. Global Medicine for Osteoarthritis Pain Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Medicine for Osteoarthritis Pain Revenue Market Share by Company (2021-2026) Table 31. Global Medicine for Osteoarthritis Pain Sales by Company (2021-2026) & (k units) Table 32. Global Medicine for Osteoarthritis Pain Sales Share by Company (2021-2026) Table 33. Global Medicine for Osteoarthritis Pain Market Price by Company (2021-2026) & (US$/unit) Table 34. Global Medicine for Osteoarthritis Pain Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Medicine for Osteoarthritis Pain Major Company Production Sites and Headquarters Table 36. Global Medicine for Osteoarthritis Pain Company, Product Type & Application Table 37. Global Medicine for Osteoarthritis Pain Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Medicine for Osteoarthritis Pain by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Medicine for Osteoarthritis Pain Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Medicine for Osteoarthritis Pain Sales by Region (2021-2026) & (k units) Table 42. Global Medicine for Osteoarthritis Pain Sales Market Share in Volume by Region (2021-2026) Table 43. Global Medicine for Osteoarthritis Pain Sales by Region (2021-2026) & (US$ Million) Table 44. Global Medicine for Osteoarthritis Pain Sales Market Share in Value by Region (2021-2026) Table 45. Global Medicine for Osteoarthritis Pain Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Global Medicine for Osteoarthritis Pain Sales by Region (2027-2032) & (k units) Table 47. Global Medicine for Osteoarthritis Pain Sales Market Share in Volume by Region (2027-2032) Table 48. Global Medicine for Osteoarthritis Pain Sales by Region (2027-2032) & (US$ Million) Table 49. Global Medicine for Osteoarthritis Pain Sales Market Share in Value by Region (2027-2032) Table 50. Global Medicine for Osteoarthritis Pain Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 51. Global Medicine for Osteoarthritis Pain Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Medicine for Osteoarthritis Pain Sales by Application (2021-2026) & (k units) Table 53. Global Medicine for Osteoarthritis Pain Sales Market Share in Volume by Application (2021-2026) Table 54. Global Medicine for Osteoarthritis Pain Sales by Application (2021-2026) & (US$ Million) Table 55. Global Medicine for Osteoarthritis Pain Sales Market Share in Value by Application (2021-2026) Table 56. Global Medicine for Osteoarthritis Pain Price by Application (2021-2026) & (US$/unit) Table 57. Global Medicine for Osteoarthritis Pain Sales by Application (2027-2032) & (k units) Table 58. Global Medicine for Osteoarthritis Pain Sales Market Share in Volume by Application (2027-2032) Table 59. Global Medicine for Osteoarthritis Pain Sales by Application (2027-2032) & (US$ Million) Table 60. Global Medicine for Osteoarthritis Pain Sales Market Share in Value by Application (2027-2032) Table 61. Global Medicine for Osteoarthritis Pain Price by Application (2027-2032) & (US$/unit) Table 62. North America Medicine for Osteoarthritis Pain Sales by Application (2021-2026) & (k units) Table 63. North America Medicine for Osteoarthritis Pain Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Medicine for Osteoarthritis Pain Sales by Application (2021-2026) & (k units) Table 65. Europe Medicine for Osteoarthritis Pain Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Medicine for Osteoarthritis Pain Sales by Application (2021-2026) & (k units) Table 67. Asia-Pacific Medicine for Osteoarthritis Pain Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Medicine for Osteoarthritis Pain Sales by Application (2021-2026) & (k units) Table 69. Latin America Medicine for Osteoarthritis Pain Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Medicine for Osteoarthritis Pain Sales by Application (2021-2026) & (k units) Table 71. Middle East and Africa Medicine for Osteoarthritis Pain Sales by Application (2021-2026) & (US$ Million) Table 72. Abbott Company Information Table 73. Abbott Business Overview Table 74. Abbott Medicine for Osteoarthritis Pain Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Abbott Medicine for Osteoarthritis Pain Product Portfolio Table 76. Abbott Recent Development Table 77. TEVA Company Information Table 78. TEVA Business Overview Table 79. TEVA Medicine for Osteoarthritis Pain Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. TEVA Medicine for Osteoarthritis Pain Product Portfolio Table 81. TEVA Recent Development Table 82. Sanofi Company Information Table 83. Sanofi Business Overview Table 84. Sanofi Medicine for Osteoarthritis Pain Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Sanofi Medicine for Osteoarthritis Pain Product Portfolio Table 86. Sanofi Recent Development Table 87. Johnson and Johnson Company Information Table 88. Johnson and Johnson Business Overview Table 89. Johnson and Johnson Medicine for Osteoarthritis Pain Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. Johnson and Johnson Medicine for Osteoarthritis Pain Product Portfolio Table 91. Johnson and Johnson Recent Development Table 92. Novartis Company Information Table 93. Novartis Business Overview Table 94. Novartis Medicine for Osteoarthritis Pain Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. Novartis Medicine for Osteoarthritis Pain Product Portfolio Table 96. Novartis Recent Development Table 97. Mylan Company Information Table 98. Mylan Business Overview Table 99. Mylan Medicine for Osteoarthritis Pain Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. Mylan Medicine for Osteoarthritis Pain Product Portfolio Table 101. Mylan Recent Development Table 102. Eli Lilly Company Information Table 103. Eli Lilly Business Overview Table 104. Eli Lilly Medicine for Osteoarthritis Pain Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. Eli Lilly Medicine for Osteoarthritis Pain Product Portfolio Table 106. Eli Lilly Recent Development Table 107. Hengrui Pharmaceutical Company Information Table 108. Hengrui Pharmaceutical Business Overview Table 109. Hengrui Pharmaceutical Medicine for Osteoarthritis Pain Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 110. Hengrui Pharmaceutical Medicine for Osteoarthritis Pain Product Portfolio Table 111. Hengrui Pharmaceutical Recent Development Table 112. Pfizer Company Information Table 113. Pfizer Business Overview Table 114. Pfizer Medicine for Osteoarthritis Pain Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 115. Pfizer Medicine for Osteoarthritis Pain Product Portfolio Table 116. Pfizer Recent Development Table 117. GlaxoSmithKline Company Information Table 118. GlaxoSmithKline Business Overview Table 119. GlaxoSmithKline Medicine for Osteoarthritis Pain Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 120. GlaxoSmithKline Medicine for Osteoarthritis Pain Product Portfolio Table 121. GlaxoSmithKline Recent Development Table 122. Daiichi Sankyo Company Information Table 123. Daiichi Sankyo Business Overview Table 124. Daiichi Sankyo Medicine for Osteoarthritis Pain Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 125. Daiichi Sankyo Medicine for Osteoarthritis Pain Product Portfolio Table 126. Daiichi Sankyo Recent Development Table 127. Bayer Company Information Table 128. Bayer Business Overview Table 129. Bayer Medicine for Osteoarthritis Pain Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 130. Bayer Medicine for Osteoarthritis Pain Product Portfolio Table 131. Bayer Recent Development Table 132. Tide Pharmaceutical Company Information Table 133. Tide Pharmaceutical Business Overview Table 134. Tide Pharmaceutical Medicine for Osteoarthritis Pain Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 135. Tide Pharmaceutical Medicine for Osteoarthritis Pain Product Portfolio Table 136. Tide Pharmaceutical Recent Development Table 137. Iroko Pharmaceuticals Company Information Table 138. Iroko Pharmaceuticals Business Overview Table 139. Iroko Pharmaceuticals Medicine for Osteoarthritis Pain Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 140. Iroko Pharmaceuticals Medicine for Osteoarthritis Pain Product Portfolio Table 141. Iroko Pharmaceuticals Recent Development Table 142. Horizon Pharma Company Information Table 143. Horizon Pharma Business Overview Table 144. Horizon Pharma Medicine for Osteoarthritis Pain Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 145. Horizon Pharma Medicine for Osteoarthritis Pain Product Portfolio Table 146. Horizon Pharma Recent Development Table 147. Astellas Pharma Company Information Table 148. Astellas Pharma Business Overview Table 149. Astellas Pharma Medicine for Osteoarthritis Pain Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 150. Astellas Pharma Medicine for Osteoarthritis Pain Product Portfolio Table 151. Astellas Pharma Recent Development Table 152. Almatica Pharma Company Information Table 153. Almatica Pharma Business Overview Table 154. Almatica Pharma Medicine for Osteoarthritis Pain Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 155. Almatica Pharma Medicine for Osteoarthritis Pain Product Portfolio Table 156. Almatica Pharma Recent Development Table 157. Abiogen Pharma Company Information Table 158. Abiogen Pharma Business Overview Table 159. Abiogen Pharma Medicine for Osteoarthritis Pain Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 160. Abiogen Pharma Medicine for Osteoarthritis Pain Product Portfolio Table 161. Abiogen Pharma Recent Development Table 162. North America Medicine for Osteoarthritis Pain Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 163. North America Medicine for Osteoarthritis Pain Sales by Country (2021-2026) & (k units) Table 164. North America Medicine for Osteoarthritis Pain Sales Market Share by Country (2021-2026) Table 165. North America Medicine for Osteoarthritis Pain Sales Forecast by Country (2027-2032) & (k units) Table 166. North America Medicine for Osteoarthritis Pain Sales Market Share Forecast by Country (2027-2032) Table 167. North America Medicine for Osteoarthritis Pain Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. North America Medicine for Osteoarthritis Pain Market Size by Country (2021-2026) & (US$ Million) Table 169. North America Medicine for Osteoarthritis Pain Market Share by Country (2021-2026) Table 170. North America Medicine for Osteoarthritis Pain Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. North America Medicine for Osteoarthritis Pain Market Share Forecast by Country (2027-2032) Table 172. Europe Medicine for Osteoarthritis Pain Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 173. Europe Medicine for Osteoarthritis Pain Sales by Country (2021-2026) & (k units) Table 174. Europe Medicine for Osteoarthritis Pain Sales Market Share by Country (2021-2026) Table 175. Europe Medicine for Osteoarthritis Pain Sales Forecast by Country (2027-2032) & (k units) Table 176. Europe Medicine for Osteoarthritis Pain Sales Market Share Forecast by Country (2027-2032) Table 177. Europe Medicine for Osteoarthritis Pain Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 178. Europe Medicine for Osteoarthritis Pain Market Size by Country (2021-2026) & (US$ Million) Table 179. Europe Medicine for Osteoarthritis Pain Market Share by Country (2021-2026) Table 180. Europe Medicine for Osteoarthritis Pain Market Size Forecast by Country (2027-2032) & (US$ Million) Table 181. Europe Medicine for Osteoarthritis Pain Market Share Forecast by Country (2027-2032) Table 182. Asia-Pacific Medicine for Osteoarthritis Pain Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 183. Asia-Pacific Medicine for Osteoarthritis Pain Sales by Country (2021-2026) & (k units) Table 184. Asia-Pacific Medicine for Osteoarthritis Pain Sales Market Share by Country (2021-2026) Table 185. Asia-Pacific Medicine for Osteoarthritis Pain Sales Forecast by Country (2027-2032) & (k units) Table 186. Asia-Pacific Medicine for Osteoarthritis Pain Sales Market Share Forecast by Country (2027-2032) Table 187. Asia-Pacific Medicine for Osteoarthritis Pain Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 188. Asia-Pacific Medicine for Osteoarthritis Pain Market Size by Country (2021-2026) & (US$ Million) Table 189. Asia-Pacific Medicine for Osteoarthritis Pain Market Share by Country (2021-2026) Table 190. Asia-Pacific Medicine for Osteoarthritis Pain Market Size Forecast by Country (2027-2032) & (US$ Million) Table 191. Asia-Pacific Medicine for Osteoarthritis Pain Market Share Forecast by Country (2027-2032) Table 192. Latin America Medicine for Osteoarthritis Pain Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 193. Latin America Medicine for Osteoarthritis Pain Sales by Country (2021-2026) & (k units) Table 194. Latin America Medicine for Osteoarthritis Pain Sales Market Share by Country (2021-2026) Table 195. Latin America Medicine for Osteoarthritis Pain Sales Forecast by Country (2027-2032) & (k units) Table 196. Latin America Medicine for Osteoarthritis Pain Sales Market Share Forecast by Country (2027-2032) Table 197. Latin America Medicine for Osteoarthritis Pain Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 198. Latin America Medicine for Osteoarthritis Pain Market Size by Country (2021-2026) & (US$ Million) Table 199. Latin America Medicine for Osteoarthritis Pain Market Share by Country (2021-2026) Table 200. Latin America Medicine for Osteoarthritis Pain Market Size Forecast by Country (2027-2032) & (US$ Million) Table 201. Latin America Medicine for Osteoarthritis Pain Market Share Forecast by Country (2027-2032) Table 202. Middle East and Africa Medicine for Osteoarthritis Pain Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 203. Middle East and Africa Medicine for Osteoarthritis Pain Sales by Country (2021-2026) & (k units) Table 204. Middle East and Africa Medicine for Osteoarthritis Pain Sales Market Share by Country (2021-2026) Table 205. Middle East and Africa Medicine for Osteoarthritis Pain Sales Forecast by Country (2027-2032) & (k units) Table 206. Middle East and Africa Medicine for Osteoarthritis Pain Sales Market Share Forecast by Country (2027-2032) Table 207. Middle East and Africa Medicine for Osteoarthritis Pain Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 208. Middle East and Africa Medicine for Osteoarthritis Pain Market Size by Country (2021-2026) & (US$ Million) Table 209. Middle East and Africa Medicine for Osteoarthritis Pain Market Share by Country (2021-2026) Table 210. Middle East and Africa Medicine for Osteoarthritis Pain Market Size Forecast by Country (2027-2032) & (US$ Million) Table 211. Middle East and Africa Medicine for Osteoarthritis Pain Market Share Forecast by Country (2027-2032) Table 212. Key Raw Materials Table 213. Raw Materials Key Suppliers Table 214. Medicine for Osteoarthritis Pain Distributors List Table 215. Medicine for Osteoarthritis Pain Customers List Table 216. Research Programs/Design for This Report Table 217. Authors List of This Report Table 218. Secondary Sources Table 219. Primary Sources List of Figures Figure 1. Medicine for Osteoarthritis Pain Image Figure 2. Global Medicine for Osteoarthritis Pain Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Medicine for Osteoarthritis Pain Market Size (2021-2032) & (US$ Million) Figure 4. Global Medicine for Osteoarthritis Pain Sales (2021-2032) & (k units) Figure 5. Injection Image Figure 6. Global Injection Sales YoY Growth (2021-2032) & (k units) Figure 7. External Image Figure 8. Global External Sales YoY Growth (2021-2032) & (k units) Figure 9. Oral Image Figure 10. Global Oral Sales YoY Growth (2021-2032) & (k units) Figure 11. Global Medicine for Osteoarthritis Pain Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Medicine for Osteoarthritis Pain Market Share by Type 2025 VS 2032 Figure 13. North America Medicine for Osteoarthritis Pain Sales Market Share in Volume by Type in 2025 Figure 14. North America Medicine for Osteoarthritis Pain Sales Market Share in Value by Type in 2025 Figure 15. Europe Medicine for Osteoarthritis Pain Sales Market Share in Volume by Type in 2025 Figure 16. Europe Medicine for Osteoarthritis Pain Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Medicine for Osteoarthritis Pain Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Medicine for Osteoarthritis Pain Sales Market Share in Value by Type in 2025 Figure 19. Latin America Medicine for Osteoarthritis Pain Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Medicine for Osteoarthritis Pain Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Medicine for Osteoarthritis Pain Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Medicine for Osteoarthritis Pain Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Medicine for Osteoarthritis Pain Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Medical Care Image Figure 26. Global Medical Care Sales YoY Growth (2021-2032) & (k units) Figure 27. Personal Care Image Figure 28. Global Personal Care Sales YoY Growth (2021-2032) & (k units) Figure 29. Global Medicine for Osteoarthritis Pain Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Medicine for Osteoarthritis Pain Market Share by Application 2025 VS 2032 Figure 31. North America Medicine for Osteoarthritis Pain Sales Market Share in Volume by Application in 2025 Figure 32. North America Medicine for Osteoarthritis Pain Sales Market Share in Value by Application in 2025 Figure 33. Europe Medicine for Osteoarthritis Pain Sales Market Share in Volume by Application in 2025 Figure 34. Europe Medicine for Osteoarthritis Pain Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Medicine for Osteoarthritis Pain Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Medicine for Osteoarthritis Pain Sales Market Share in Value by Application in 2025 Figure 37. Latin America Medicine for Osteoarthritis Pain Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Medicine for Osteoarthritis Pain Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Medicine for Osteoarthritis Pain Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Medicine for Osteoarthritis Pain Sales Market Share in Value by Application in 2025 Figure 41. North America Medicine for Osteoarthritis Pain Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 42. North America Medicine for Osteoarthritis Pain Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Medicine for Osteoarthritis Pain Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Medicine for Osteoarthritis Pain Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Medicine for Osteoarthritis Pain Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. Europe Medicine for Osteoarthritis Pain Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Medicine for Osteoarthritis Pain Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Medicine for Osteoarthritis Pain Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Medicine for Osteoarthritis Pain Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Asia-Pacific Medicine for Osteoarthritis Pain Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Medicine for Osteoarthritis Pain Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Medicine for Osteoarthritis Pain Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Medicine for Osteoarthritis Pain Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Latin America Medicine for Osteoarthritis Pain Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Medicine for Osteoarthritis Pain Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Medicine for Osteoarthritis Pain Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Medicine for Osteoarthritis Pain Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Middle East and Africa Medicine for Osteoarthritis Pain Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Medicine for Osteoarthritis Pain Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Medicine for Osteoarthritis Pain Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Medicine for Osteoarthritis Pain Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Medicine for Osteoarthritis Pain Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Injection
  • External
  • Oral
Applications
  • Medical Care
  • Personal Care
Companies covered
  • Abbott
  • TEVA
  • Sanofi
  • Johnson and Johnson
  • Novartis
  • Mylan
  • Eli Lilly
  • Hengrui Pharmaceutical
  • Pfizer
  • GlaxoSmithKline
  • Daiichi Sankyo
  • Bayer
  • Tide Pharmaceutical
  • Iroko Pharmaceuticals
  • Horizon Pharma
  • Astellas Pharma
  • Almatica Pharma
  • Abiogen Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Medicine for Osteoarthritis Pain Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Medicine for Osteoarthritis Pain Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Medicine for Osteoarthritis Pain Market by Type
  6. 1.3.1 Injection
  7. 1.3.2 External
  8. 1.3.3 Oral
  9. 1.4 Global Medicine for Osteoarthritis Pain Market Size by Type
  10. 1.4.1 Global Medicine for Osteoarthritis Pain Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Medicine for Osteoarthritis Pain Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Medicine for Osteoarthritis Pain Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Medicine for Osteoarthritis Pain Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Medicine for Osteoarthritis Pain Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Medicine for Osteoarthritis Pain Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Medicine for Osteoarthritis Pain Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Medicine for Osteoarthritis Pain Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Medicine for Osteoarthritis Pain Industry Trends
  2. 2.2 Medicine for Osteoarthritis Pain Industry Drivers
  3. 2.3 Medicine for Osteoarthritis Pain Industry Opportunities and Challenges
  4. 2.4 Medicine for Osteoarthritis Pain Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Medicine for Osteoarthritis Pain Revenue (2021-2026)
  2. 3.2 Global Top Players by Medicine for Osteoarthritis Pain Sales (2021-2026)
  3. 3.3 Global Top Players by Medicine for Osteoarthritis Pain Price (2021-2026)
  4. 3.4 Global Medicine for Osteoarthritis Pain Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Medicine for Osteoarthritis Pain Major Company Production Sites & Headquarters
  6. 3.6 Global Medicine for Osteoarthritis Pain Company, Product Type & Application
  7. 3.7 Global Medicine for Osteoarthritis Pain Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Medicine for Osteoarthritis Pain Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Medicine for Osteoarthritis Pain Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Medicine for Osteoarthritis Pain Tier 1, Tier 2, and Tier 3
4 Medicine for Osteoarthritis Pain Regional Status and Outlook
  1. 4.1 Global Medicine for Osteoarthritis Pain Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Medicine for Osteoarthritis Pain Historic Market Size by Region
  3. 4.2.1 Global Medicine for Osteoarthritis Pain Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Medicine for Osteoarthritis Pain Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Medicine for Osteoarthritis Pain Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Medicine for Osteoarthritis Pain Forecasted Market Size by Region
  7. 4.3.1 Global Medicine for Osteoarthritis Pain Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Medicine for Osteoarthritis Pain Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Medicine for Osteoarthritis Pain Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Medicine for Osteoarthritis Pain by Application
  1. 5.1 Medicine for Osteoarthritis Pain Market by Application
  2. 5.1.1 Medical Care
  3. 5.1.2 Personal Care
  4. 5.2 Global Medicine for Osteoarthritis Pain Market Size by Application
  5. 5.2.1 Global Medicine for Osteoarthritis Pain Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Medicine for Osteoarthritis Pain Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Medicine for Osteoarthritis Pain Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Medicine for Osteoarthritis Pain Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Medicine for Osteoarthritis Pain Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Medicine for Osteoarthritis Pain Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Medicine for Osteoarthritis Pain Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Medicine for Osteoarthritis Pain Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Abbott
  2. 6.1.1 Abbott Company Information
  3. 6.1.2 Abbott Business Overview
  4. 6.1.3 Abbott Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Abbott Medicine for Osteoarthritis Pain Product Portfolio
  6. 6.1.5 Abbott Recent Developments
  7. 6.2 TEVA
  8. 6.2.1 TEVA Company Information
  9. 6.2.2 TEVA Business Overview
  10. 6.2.3 TEVA Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 TEVA Medicine for Osteoarthritis Pain Product Portfolio
  12. 6.2.5 TEVA Recent Developments
  13. 6.3 Sanofi
  14. 6.3.1 Sanofi Company Information
  15. 6.3.2 Sanofi Business Overview
  16. 6.3.3 Sanofi Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sanofi Medicine for Osteoarthritis Pain Product Portfolio
  18. 6.3.5 Sanofi Recent Developments
  19. 6.4 Johnson and Johnson
  20. 6.4.1 Johnson and Johnson Company Information
  21. 6.4.2 Johnson and Johnson Business Overview
  22. 6.4.3 Johnson and Johnson Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Johnson and Johnson Medicine for Osteoarthritis Pain Product Portfolio
  24. 6.4.5 Johnson and Johnson Recent Developments
  25. 6.5 Novartis
  26. 6.5.1 Novartis Company Information
  27. 6.5.2 Novartis Business Overview
  28. 6.5.3 Novartis Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Novartis Medicine for Osteoarthritis Pain Product Portfolio
  30. 6.5.5 Novartis Recent Developments
  31. 6.6 Mylan
  32. 6.6.1 Mylan Company Information
  33. 6.6.2 Mylan Business Overview
  34. 6.6.3 Mylan Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Mylan Medicine for Osteoarthritis Pain Product Portfolio
  36. 6.6.5 Mylan Recent Developments
  37. 6.7 Eli Lilly
  38. 6.7.1 Eli Lilly Company Information
  39. 6.7.2 Eli Lilly Business Overview
  40. 6.7.3 Eli Lilly Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Eli Lilly Medicine for Osteoarthritis Pain Product Portfolio
  42. 6.7.5 Eli Lilly Recent Developments
  43. 6.8 Hengrui Pharmaceutical
  44. 6.8.1 Hengrui Pharmaceutical Company Information
  45. 6.8.2 Hengrui Pharmaceutical Business Overview
  46. 6.8.3 Hengrui Pharmaceutical Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Hengrui Pharmaceutical Medicine for Osteoarthritis Pain Product Portfolio
  48. 6.8.5 Hengrui Pharmaceutical Recent Developments
  49. 6.9 Pfizer
  50. 6.9.1 Pfizer Company Information
  51. 6.9.2 Pfizer Business Overview
  52. 6.9.3 Pfizer Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Pfizer Medicine for Osteoarthritis Pain Product Portfolio
  54. 6.9.5 Pfizer Recent Developments
  55. 6.10 GlaxoSmithKline
  56. 6.10.1 GlaxoSmithKline Company Information
  57. 6.10.2 GlaxoSmithKline Business Overview
  58. 6.10.3 GlaxoSmithKline Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 GlaxoSmithKline Medicine for Osteoarthritis Pain Product Portfolio
  60. 6.10.5 GlaxoSmithKline Recent Developments
  61. 6.11 Daiichi Sankyo
  62. 6.11.1 Daiichi Sankyo Company Information
  63. 6.11.2 Daiichi Sankyo Business Overview
  64. 6.11.3 Daiichi Sankyo Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Daiichi Sankyo Medicine for Osteoarthritis Pain Product Portfolio
  66. 6.11.5 Daiichi Sankyo Recent Developments
  67. 6.12 Bayer
  68. 6.12.1 Bayer Company Information
  69. 6.12.2 Bayer Business Overview
  70. 6.12.3 Bayer Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Bayer Medicine for Osteoarthritis Pain Product Portfolio
  72. 6.12.5 Bayer Recent Developments
  73. 6.13 Tide Pharmaceutical
  74. 6.13.1 Tide Pharmaceutical Company Information
  75. 6.13.2 Tide Pharmaceutical Business Overview
  76. 6.13.3 Tide Pharmaceutical Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Tide Pharmaceutical Medicine for Osteoarthritis Pain Product Portfolio
  78. 6.13.5 Tide Pharmaceutical Recent Developments
  79. 6.14 Iroko Pharmaceuticals
  80. 6.14.1 Iroko Pharmaceuticals Company Information
  81. 6.14.2 Iroko Pharmaceuticals Business Overview
  82. 6.14.3 Iroko Pharmaceuticals Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Iroko Pharmaceuticals Medicine for Osteoarthritis Pain Product Portfolio
  84. 6.14.5 Iroko Pharmaceuticals Recent Developments
  85. 6.15 Horizon Pharma
  86. 6.15.1 Horizon Pharma Company Information
  87. 6.15.2 Horizon Pharma Business Overview
  88. 6.15.3 Horizon Pharma Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Horizon Pharma Medicine for Osteoarthritis Pain Product Portfolio
  90. 6.15.5 Horizon Pharma Recent Developments
  91. 6.16 Astellas Pharma
  92. 6.16.1 Astellas Pharma Company Information
  93. 6.16.2 Astellas Pharma Business Overview
  94. 6.16.3 Astellas Pharma Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Astellas Pharma Medicine for Osteoarthritis Pain Product Portfolio
  96. 6.16.5 Astellas Pharma Recent Developments
  97. 6.17 Almatica Pharma
  98. 6.17.1 Almatica Pharma Company Information
  99. 6.17.2 Almatica Pharma Business Overview
  100. 6.17.3 Almatica Pharma Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Almatica Pharma Medicine for Osteoarthritis Pain Product Portfolio
  102. 6.17.5 Almatica Pharma Recent Developments
  103. 6.18 Abiogen Pharma
  104. 6.18.1 Abiogen Pharma Company Information
  105. 6.18.2 Abiogen Pharma Business Overview
  106. 6.18.3 Abiogen Pharma Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Abiogen Pharma Medicine for Osteoarthritis Pain Product Portfolio
  108. 6.18.5 Abiogen Pharma Recent Developments
7 North America by Country
  1. 7.1 North America Medicine for Osteoarthritis Pain Sales by Country
  2. 7.1.1 North America Medicine for Osteoarthritis Pain Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Medicine for Osteoarthritis Pain Sales by Country (2021-2026)
  4. 7.1.3 North America Medicine for Osteoarthritis Pain Sales Forecast by Country (2027-2032)
  5. 7.2 North America Medicine for Osteoarthritis Pain Market Size by Country
  6. 7.2.1 North America Medicine for Osteoarthritis Pain Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Medicine for Osteoarthritis Pain Market Size by Country (2021-2026)
  8. 7.2.3 North America Medicine for Osteoarthritis Pain Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Medicine for Osteoarthritis Pain Sales by Country
  2. 8.1.1 Europe Medicine for Osteoarthritis Pain Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Medicine for Osteoarthritis Pain Sales by Country (2021-2026)
  4. 8.1.3 Europe Medicine for Osteoarthritis Pain Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Medicine for Osteoarthritis Pain Market Size by Country
  6. 8.2.1 Europe Medicine for Osteoarthritis Pain Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Medicine for Osteoarthritis Pain Market Size by Country (2021-2026)
  8. 8.2.3 Europe Medicine for Osteoarthritis Pain Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Medicine for Osteoarthritis Pain Sales by Country
  2. 9.1.1 Asia-Pacific Medicine for Osteoarthritis Pain Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Medicine for Osteoarthritis Pain Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Medicine for Osteoarthritis Pain Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Medicine for Osteoarthritis Pain Market Size by Country
  6. 9.2.1 Asia-Pacific Medicine for Osteoarthritis Pain Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Medicine for Osteoarthritis Pain Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Medicine for Osteoarthritis Pain Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Medicine for Osteoarthritis Pain Sales by Country
  2. 10.1.1 South America Medicine for Osteoarthritis Pain Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Medicine for Osteoarthritis Pain Sales by Country (2021-2026)
  4. 10.1.3 South America Medicine for Osteoarthritis Pain Sales Forecast by Country (2027-2032)
  5. 10.2 South America Medicine for Osteoarthritis Pain Market Size by Country
  6. 10.2.1 South America Medicine for Osteoarthritis Pain Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Medicine for Osteoarthritis Pain Market Size by Country (2021-2026)
  8. 10.2.3 South America Medicine for Osteoarthritis Pain Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Medicine for Osteoarthritis Pain Sales by Country
  2. 11.1.1 Middle East and Africa Medicine for Osteoarthritis Pain Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Medicine for Osteoarthritis Pain Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Medicine for Osteoarthritis Pain Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Medicine for Osteoarthritis Pain Market Size by Country
  6. 11.2.1 Middle East and Africa Medicine for Osteoarthritis Pain Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Medicine for Osteoarthritis Pain Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Medicine for Osteoarthritis Pain Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Medicine for Osteoarthritis Pain Value Chain Analysis
  2. 12.1.1 Medicine for Osteoarthritis Pain Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Medicine for Osteoarthritis Pain Production Mode & Process
  7. 12.2 Medicine for Osteoarthritis Pain Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Medicine for Osteoarthritis Pain Distributors
  10. 12.2.3 Medicine for Osteoarthritis Pain Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst